EZZ Life Science Holdings Limited (ASX:EZZ)
Australia flag Australia · Delayed Price · Currency is AUD
1.560
-0.075 (-4.59%)
Feb 19, 2026, 3:59 PM AEST

EZZ Life Science Holdings Income Statement

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Operating Revenue
66.8766.4437.1415.0222.29
66.8766.4437.1415.0222.29
Revenue Growth (YoY)
0.65%78.88%147.26%-32.60%24.03%
Cost of Revenue
17.1515.58.617.519.83
Gross Profit
49.7250.9528.537.5112.46
Selling, General & Admin
35.8738.4921.74.148.68
Other Operating Expenses
3.412.352.031.460.9
Operating Expenses
39.7941.2323.915.729.71
Operating Income
9.939.724.621.782.75
Interest Expense
-0.03-0.02-0.01-0-0.01
Interest & Investment Income
0.420.20.040-
Currency Exchange Gain (Loss)
0.240.070.22--
Other Non Operating Income (Expenses)
0.03-0.04--
Pretax Income
10.599.964.91.782.74
Income Tax Expense
3.862.991.270.470.71
Net Income
6.736.963.631.312.03
Net Income to Common
6.736.963.631.312.03
Net Income Growth
-3.36%91.87%176.57%-35.37%28.02%
Shares Outstanding (Basic)
4643434334
Shares Outstanding (Diluted)
4643434334
Shares Change (YoY)
7.35%0.89%0.46%25.23%13.15%
EPS (Basic)
0.150.160.080.030.06
EPS (Diluted)
0.150.160.080.030.06
EPS Growth
-9.99%90.19%175.31%-48.37%13.10%
Free Cash Flow
4.135.733.911.90.25
Free Cash Flow Per Share
0.090.130.090.040.01
Dividend Per Share
0.0400.0350.0200.0040.004
Dividend Growth
14.29%76.77%340.00%--
Gross Margin
74.35%76.68%76.81%49.98%55.90%
Operating Margin
14.85%14.62%12.43%11.88%12.33%
Profit Margin
10.06%10.48%9.77%8.74%9.11%
Free Cash Flow Margin
6.17%8.63%10.53%12.62%1.11%
EBITDA
10.089.754.631.82.76
EBITDA Margin
15.08%14.68%12.48%11.98%12.41%
D&A For EBITDA
0.150.030.020.020.02
EBIT
9.939.724.621.782.75
EBIT Margin
14.85%14.62%12.43%11.88%12.33%
Effective Tax Rate
36.42%30.07%25.93%26.26%25.80%
Advertising Expenses
32.2737.2320.562.977.84
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.